Every Form 4 that Icf Intl Inc (ICFI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow ICFI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ICFI filings page.
ICF International, Inc. (ICFI) reported that CEO and President John Wasson, through the John M. Wasson Remainder Trust 2022, sold a total of 6,400 shares of common stock on September 1, 2026 under a Rule 10b5-1 trading plan adopted on March 7, 2026. The trust sold 585 shares at a weighted average price of $89.68 and 5,815 shares at a weighted average price of $88.18, in multiple transactions within stated price ranges. Following the reported transactions, Wasson is shown holding 21,582 shares directly, and indirect holdings of 716 shares by spouse, 27,511 shares in the John M. Wasson Rev. Trust, and 39,212 shares in the JW 26 GRAT.
ICF International, Inc. (ICFI) reported that Executive Vice President Sergio J. Ostria sold 2,000 shares of common stock on 2026-08-26 in an open market or private transaction. The weighted average sale price was $88.5915 per share, and his directly held stake after the sale is 24,467 shares.
ICF International, Inc. CEO & President John Wasson reported an open-market sale of 12,411 shares of common stock by the John M. Wasson Rev. Trust, an indirect holding entity, at a weighted average price of $80.0836 on July 13, 2026 under a Rule 10b5-1 trading plan adopted March 7, 2026. Following the sale, that trust held 27,511 shares, and Wasson also reported indirect holdings of 39,212 shares in a JW 26 GRAT, 12,739 shares in a remainder trust, 716 shares held by his spouse, plus 21,582 shares held directly.
Williams Michelle A reported acquisition or exercise transactions in this Form 4 filing.
ICF International director Michelle A. Williams reported a grant of 2,277 restricted stock units as her annual equity award. The award was made under the ICF International, Inc. 2026 Omnibus Incentive Plan and carries no cash purchase price.
These restricted stock units will vest on the one-year anniversary of the July 1 grant date. Following this equity award, Williams now holds 8,498 shares of common stock directly, reflecting a routine compensation-related increase in her ownership.
VAN HANDEL MICHAEL J reported acquisition or exercise transactions in this Form 4 filing.
ICF International, Inc. director Michael J. Van Handel received an equity grant of 2,277 shares of common stock as a restricted stock unit award. The award was granted at a stated price of $0.00 per share as part of his annual equity compensation under the company’s 2026 Omnibus Incentive Plan.
These restricted stock units will vest on the one-year anniversary of the July 1 grant date. Following this grant, Van Handel directly holds 26,531 shares of ICF International common stock.
SALMIRS SCOTT B reported acquisition or exercise transactions in this Form 4 filing.
ICF International director Scott B. Salmirs received an equity grant of 2,277 restricted stock units. The award was granted under the ICF International, Inc. 2026 Omnibus Incentive Plan as his annual equity award. These restricted stock units vest on the one-year anniversary of the July 1 grant date. Following this grant, he directly holds 11,650 shares of common stock.
Mehl Randall reported acquisition or exercise transactions in this Form 4 filing.
ICF International, Inc. director Randall Mehl received an equity compensation award of 2,277 shares of common stock on July 1, 2026. The award is in the form of restricted stock units granted under the ICF International, Inc. 2026 Omnibus Incentive Plan and represents his annual equity award. These units will vest on the one-year anniversary of the grant date. Following this grant, Mehl directly holds 23,851 common shares.
Datar Srikant M. reported acquisition or exercise transactions in this Form 4 filing.
ICF International, Inc. director Srikant M. Datar received an equity grant of 2,277 shares of common stock in the form of restricted stock units under the company’s 2026 Omnibus Incentive Plan. The award represents his annual equity grant and will vest on the one-year anniversary of the July 1 grant date.
Following this grant, Datar directly holds 5,998 common shares. He also has indirect ownership of 33,428 common shares through Safari Investments and 6,851 common shares through LegacyCap LLC, reflecting additional positions held via affiliated entities.
ICF International CEO and President John Wasson acquired 279 shares of common stock through the company’s Employee Stock Purchase Plan. The shares were purchased for the ESPP offering period from January 2, 2026 through June 30, 2026, at a price not less than ninety-five percent of the per-share fair market value on June 30, 2026. After this ESPP acquisition, he held 21,582 shares directly, in addition to indirect holdings in several trusts and by his spouse. The transaction is described as exempt under Rule 16b-3(c).
Crouther Marilyn C reported acquisition or exercise transactions in this Form 4 filing.
ICF International director Marilyn C. Crouther received an award of 2,277 restricted stock units as her annual equity grant under the ICF International, Inc. 2026 Omnibus Incentive Plan. These units vest on the one-year anniversary of the July 1 grant date. Following this award, she directly holds 10,859 common shares.
ICF International, Inc. director Caroline Angoorly received an equity grant as part of her annual compensation. She acquired 2,277 shares of common stock in the form of restricted stock units under the ICF International, Inc. 2026 Omnibus Incentive Plan. These restricted stock units will vest on the one-year anniversary of the July 1 grant date. Following this award, her directly held common stock position reported in the filing totals 4,441 shares.
ICF International director Michael J. Van Handel reported buying 8,000 shares of ICF International, Inc. common stock in open-market transactions. On May 15, 2026, he made two purchases of 4,000 shares each at weighted average prices of $61.20 and $61.5835 per share, in accordance with the issuer's trading policies. After these transactions, he directly owned 24,254 common shares.
ICF International, Inc. CEO & President John Wasson reported a mix of equity award activity and related tax withholding. He received a grant of 36,443 restricted stock units (RSUs), each equivalent to one common share, under the company’s 2018 Omnibus Incentive Plan, vesting 25% on each of the first two anniversaries and 50% on the third.
On the same date, 18,367 previously granted RSUs vested and were exercised into common stock through three transactions of 3,379, 7,312, and 7,676 units. To satisfy tax obligations, a total of 8,284 common shares were withheld at $65.89 per share across three dispositions, rather than sold on the open market. After these transactions, Wasson directly holds 21,303 common shares and continues to hold additional shares indirectly through his spouse and various personal trusts.
ICF International Executive Vice President Sergio J. Ostria reported routine equity compensation activity. He received a grant of 3,766 restricted stock units (RSUs) under the company’s 2018 Omnibus Incentive Plan. These RSUs vest over three years, with 25% on each of the first two anniversaries and 50% on the third.
On the same date, previously granted RSUs vested and were exercised into 2,847 shares of common stock at an exercise price of $65.89 per share, as disclosed. To cover tax obligations, 950 shares of common stock were disposed of through tax withholding, not open‑market sales. After these transactions, Ostria directly holds 26,467 shares of ICF International common stock.
ICF International, Inc. Chief Operating Officer James C. M. Morgan reported compensation-related equity activity involving restricted stock units and common shares. On 2026-03-20, he received a grant of 12,133 restricted stock units, each equivalent to one share of common stock, under the company’s 2018 Omnibus Incentive Plan. The filing also shows exercises of previously granted restricted stock units covering 7,588 shares of common stock tied to first, second, and third vesting anniversaries. To cover tax obligations at an exercise price of $65.89 per share, 1,983 common shares were withheld rather than sold on the open market. After these transactions, Morgan directly holds 49,683 shares of common stock and 32,476 restricted stock units, indicating a sizeable continuing equity stake.
ICF International Executive Vice President Anne F. Choate reported equity compensation activity involving restricted stock units and common shares. On March 20, 2026, she received a grant of 7,090 restricted stock units under the 2018 Omnibus Incentive Plan, which vest over three years at 25%, 25%, and 50% on successive anniversaries.
On the same date, previously granted restricted stock units vested and were exercised in three tranches of 435, 1,053, and 1,732 units, converting into the same number of common shares at an exercise price of $65.89 per share, described as the economic equivalent of one common share per unit. To cover tax obligations and/or exercise costs, 136, 329, and 540 common shares were withheld at $65.89 per share.
Following these transactions, Choate directly holds 10,480 shares of common stock and 14,970 restricted stock units, reflecting a routine mix of equity award grants, vesting, and tax withholding rather than open-market buying or selling.
ICF International VP & Principal Accounting Officer Ranjit S. Chadha reported routine equity compensation activity. He received a grant of 813 restricted stock units, each economically equivalent to one share of ICF International common stock, under the company’s 2018 Omnibus Incentive Plan.
On the same date, several previously granted restricted stock units vested and were exercised into a total of 898 common shares, while 107 shares were withheld at a price of $65.89 per share to cover tax liabilities. Following these transactions, Chadha directly holds 258 shares of common stock and 1,609 restricted stock units.
ICF International, Inc. director Randall Mehl bought additional common shares of the company. He completed an open-market purchase of 1,100 shares at a price of $74.30 per share, in accordance with the issuer's trading policies. After this transaction, he directly owns 21,574 common shares.
ICF International, Inc. insider John Wasson, the CEO and President, reported an internal reallocation of common stock among his indirect ownership accounts. On March 3, 2026, 39,212 shares of common stock were transferred from his Revocable Trust to the JW 26 GRAT at a stated price of $0.00 per share, reflecting an estate or ownership structuring move rather than a market trade.
After these transfers, Wasson indirectly held 39,922 common shares through the John M. Wasson Rev. Trust and 39,212 common shares through the JW 26 GRAT. He also held 11,220 common shares directly, with additional indirect holdings of 716 common shares through his spouse and 12,739 common shares through the John M. Wasson Remainder Trust 2022 as of the same date.
ICF International Executive Vice President Sergio J. Ostria reported equity compensation activity in the company’s common stock. On January 20, 2026, he acquired 1,996 common shares at $0.00 per share, reflecting the vesting of a 2023 performance share award after specified performance criteria were met. On the same date, 751 vested shares were withheld at $94.53 per share to cover related tax obligations. After these transactions, he directly held 24,570 common shares of ICF International.
ICF International Executive Vice President Anne F. Choate reported equity-based compensation activity in company stock. On January 20, 2026, she acquired 2,370 shares of common stock at a price of $0.0000 per share, reflecting the vesting of a 2023 performance share award after its performance criteria were met. On the same date, 822 shares underlying the vested performance shares were withheld at $94.53 per share to cover related tax obligations. After these transactions, Choate directly held 8,265 shares of ICF International common stock.
ICF International, Inc. Chief Financial Officer Broadus Barry M reported equity compensation activity involving the company’s common stock. On January 20, 2026, he acquired 3,081 shares of common stock at $0.0000 per share, reflecting the vesting of a 2023 performance share award after its performance criteria were met. On the same date, 1,010 shares were withheld at a price of $94.53 per share to cover related tax obligations on the vested shares. Following these transactions, he directly owned 9,610 shares of ICF International common stock.
ICF International, Inc. (ICFI) Chief Operating Officer Morgan James C M reported the vesting of a performance share award on January 20, 2026. A total of 5,906 shares of common stock were acquired at a price of $0.0000 per share, reflecting the vesting of a 2023 performance share award after required performance criteria were achieved.
On the same date, 1,532 shares underlying the vested performance shares were withheld at $94.53 per share to pay related tax liabilities. Following these transactions, the COO directly holds 44,078 shares of ICF International common stock.
ICF International CEO & President John Wasson reported equity compensation activity involving ICF International, Inc. common stock. On January 20, 2026, he acquired 17,272 shares of common stock at $0.0000 per share, reflecting the vesting of a 2023 performance share award after performance criteria were met. On the same date, 6,283 shares from the vested performance shares were withheld at $94.53 per share to cover related tax obligations.
After these transactions, Wasson held 11,220 common shares directly. He also had indirect holdings of 716 shares through his spouse, 12,739 shares through the John M. Wasson Remainder Trust 2022, and 79,134 shares through the John M. Wasson Revocable Trust.
ICF International (ICFI) director reported open-market purchases of common stock. On 11/14/2025, the director bought 346 shares at $78.20 and 154 shares at $78.00. On 11/17/2025, the director bought an additional 500 shares at $77.00. After these transactions, the director beneficially owned 20,474 shares of ICF International common stock, held directly. The purchases were described as open market transactions made in accordance with the company’s trading policies.
ICF International (ICFI) reported an insider transaction by an Executive Vice President. On 11/07/2025, the officer exercised derivative securities and acquired 980 shares of common stock (Code M), followed by a disposition of 306 shares at $81.81 per share (Code F). After these transactions, the officer beneficially owned 6,717 common shares.
The filing also shows 11,100 restricted stock units beneficially owned following the reported transactions. A footnote states the exercise price for the restricted stock unit exercise was $81.81, and another footnote notes the activity represents the second vesting anniversary (25%) of RSUs granted under the 2018 Omnibus Incentive Plan, as amended.
Insider sale under a pre-established plan: The Form 4 shows Chief Operating Officer Morgan James C. M. sold 2,400 shares of ICF International (ICFI) on 10/02/2025 at a weighted-average price of $95.1943 per share. After the sale the reporting person beneficially owned 39,704 shares. The filing states the transactions were executed under a Rule 10b5-1 trading plan adopted earlier and amended on 05/27/2025, and that the reported price is a weighted average of multiple sales between $95.00 and $95.38. The Form is signed by an attorney-in-fact on 10/06/2025.
Reporting person: Morgan James C M, identified as an officer (Chief Operating Officer) of ICF International, Inc. (ICFI). The Form 4 shows a sale of 100 shares of common stock on 09/25/2025 at a reported price of $95 per share. After the reported transaction the reporting person beneficially owned 42,104 shares, held directly. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and amended on May 27, 2025. The form is signed by an attorney-in-fact, James E. Daniel, dated 09/29/2025.